Bexlosteride

Bexlosteride
Clinical data
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • Uncontrolled
Identifiers
Synonyms LY 300502
CAS Number 148905-78-6 N
PubChem (CID) 166562
ChemSpider 145762 YesY
UNII 36X732P4P0 YesY
ChEMBL CHEMBL24955 YesY
Chemical and physical data
Formula C14H16ClNO
Molar mass 249.73594 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Bexlosteride is a potent and noncompetitive inhibitor of the enzyme 5α-reductase related to finasteride and dutasteride.[1][2] It is selective for the type I isoform of the enzyme.[1] It advanced to Phase III clinical trials, but development was halted at that stage, and it was never marketed.[3][4]

See also

References

  1. 1 2 Chang, Chawnshang (2002). Androgens and androgen receptor : mechanisms, functions, and clinical application. Boston: Kluwer Academic Publishers. ISBN 1-4020-7188-4.
  2. Lednicer, Daniel (2008). Strategies for Organic Drug Synthesis and Design. New York: Wiley-Interscience. ISBN 0-470-19039-6.
  3. "Drug Profile: Bexlosteride". Adis Insight.
  4. Reaxys entry for bexlosteride: Reaxys Registry Number: 6635310
This article is issued from Wikipedia - version of the 12/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.